Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	285.07	291.67	188.64	203.42	287.76	544.83
Cash & Short-Term Investments	285.07	291.67	188.64	203.42	287.76	544.83
Cash Growth	37.02%	54.62%	-7.27%	-29.31%	-47.18%	-15.73%
Accounts Receivable	9.92	7.47	8.94	20.28	12	66.67
Other Receivables	11.56	11.42	0.49	0.53	0.86	0.7
Receivables	21.48	18.9	9.43	20.82	12.86	67.38
Inventory	94.88	89.51	118.22	98.13	84.88	64.75
Prepaid Expenses	-	-	1.83	2.6	-	-
Other Current Assets	3.09	3.31	26.06	29.94	45.3	46.48
Total Current Assets	404.52	403.39	344.18	354.9	430.8	723.43
Property, Plant & Equipment	127.56	135.79	165.95	176.77	172.58	139.16
Long-Term Investments	-	-	14	18.95	33.65	5
Goodwill	46.22	46.22	-	-	-	2.58
Other Intangible Assets	179.74	189.31	53.4	52.87	73.92	82.07
Long-Term Deferred Tax Assets	108.92	111.88	105.33	91.78	44.17	5.86
Long-Term Deferred Charges	418.17	413.88	375.91	369.2	333.07	253.06
Other Long-Term Assets	0.17	0.08	127.05	3.14	14.89	6.34
Total Assets	1,285	1,301	1,186	1,068	1,103	1,217
Accounts Payable	21.41	20.83	20.12	13.41	8.57	20.07
Accrued Expenses	14.38	29.32	57.65	62.19	55.18	63.38
Short-Term Debt	86.47	53.05	53.55	35.54	5.01	-
Current Portion of Long-Term Debt	14.85	16.07	0.76	-	-	-
Current Portion of Leases	-	-	14.96	10.95	11.78	-
Current Income Taxes Payable	4.43	8.79	-	-	-	0.13
Current Unearned Revenue	0.92	1.87	1.12	0.79	0.41	0.79
Other Current Liabilities	37.65	62.08	3.12	9.3	11.6	7.8
Total Current Liabilities	180.11	192.02	151.27	132.18	92.56	92.18
Long-Term Debt	137	54.8	105.3	-	-	-
Long-Term Leases	16.42	18.99	24.92	11.83	27.49	-
Long-Term Unearned Revenue	10.54	13.32	21	2	1.94	2.48
Long-Term Deferred Tax Liabilities	39.45	40.89	20.22	22.72	21.47	17.53
Other Long-Term Liabilities	-	82.2	1.46	11.4	14.47	27.44
Total Liabilities	383.52	402.22	324.17	180.13	157.92	139.63
Common Stock	413.46	413.46	410	410	410	410
Additional Paid-In Capital	652.58	651.98	608.92	596.87	527.37	545.23
Retained Earnings	-196.47	-199.44	-200.94	-161.31	-8.44	122.33
Comprehensive Income & Other	1.01	0.89	1.97	1.52	-1.09	0.31
Total Common Equity	870.57	866.89	819.96	847.08	927.84	1,078
Minority Interest	31.2	31.45	41.69	40.4	17.33	-
Shareholders' Equity	901.77	898.34	861.65	887.48	945.16	1,078
Total Liabilities & Equity	1,285	1,301	1,186	1,068	1,103	1,217
Total Debt	254.74	142.91	199.49	58.31	44.27	-
Net Cash (Debt)	30.33	148.76	-10.85	145.11	243.48	544.83
Net Cash Growth	-	-	-	-40.40%	-55.31%	-15.73%
Net Cash Per Share	0.09	0.40	-0.03	0.36	0.60	1.33
Filing Date Shares Outstanding	413.46	413.46	410	410	410	410
Total Common Shares Outstanding	413.46	413.46	410	410	410	410
Working Capital	224.41	211.37	192.9	222.72	338.24	631.26
Book Value Per Share	2.11	2.10	2.00	2.07	2.26	2.63
Tangible Book Value	644.62	631.36	766.55	794.21	853.92	993.22
Tangible Book Value Per Share	1.56	1.53	1.87	1.94	2.08	2.42
Machinery	-	-	286	278.74	226.45	179.29
Construction In Progress	-	-	1.55	6.66	11.92	40.94

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.